Dr Lalchandani Lab Key Ratios
BSE: 541299
₹8.22
₹0.38
(4.85%)
As on 11-Sep-2026IST
Market cap
₹7 Cr
Revenue (TTM)
₹4 Cr
P/E Ratio
112.7
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -7.40 | -26.63 | -6.11 |
| EBIT | -- | -- | 176.70 | -42.46 | -15.75 |
| Net Profit | -- | -- | -32.44 | -23.54 | -2.53 |
| EPS | -- | -- | -32.44 | -23.54 | -2.53 |
| Book Value | -- | -- | 4.38 | -1.35 | 3.97 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -4.35 | 4.27 | 8.06 | -9.73 | -11.38 |
| Net Margin
| -3.16 | -0.30 | 9.35 | 12.14 | -30.98 |
| Return on equity
| -1.75 | 3.16 | 4.29 | 6.70 | -16.23 |
| Return on Capital
| 2.33 | 6.99 | 3.61 | 7.07 | -3.69 |
| Return on Assets
| -0.74 | 2.17 | 2.71 | 3.78 | -8.72 |
| Debt to Equity (x)
| -- | -- | 0.41 | 0.37 | 0.72 |
Profitability
ROCE
3.61
Higher than Peers by 5.83
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
3.61
|
7.07
|
-3.69
|
13.07
|
14.88
|
|
Peer Median
|
-2.22
|
4.55
|
13.69
|
4.09
|
--
|
ROE
4.29
Higher than Peers by 7.85
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
4.29
|
6.70
|
-16.23
|
9.49
|
11.56
|
|
Peer Median
|
-3.56
|
2.06
|
12.85
|
3.02
|
--
|
ROA
2.71
Higher than Peers by 5.45
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
2.71
|
3.78
|
-8.72
|
5.60
|
7.46
|
|
Peer Median
|
-2.73
|
1.49
|
9.99
|
2.71
|
--
|
EBIT Margin
8.06
Lower than Peers by 0.14
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
8.06
|
-9.73
|
-11.38
|
16.70
|
17.71
|
|
Peer Median
|
8.20
|
8.08
|
9.36
|
11.52
|
--
|
Net Margin
9.35
Higher than Peers by 9.36
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
9.35
|
12.14
|
-30.98
|
8.27
|
10.34
|
|
Peer Median
|
-0.01
|
3.55
|
11.92
|
4.74
|
--
|
Cash Profit Margin
22.04
Higher than Peers by 22.04
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
22.04
|
25.82
|
-17.85
|
13.49
|
15.61
|
|
Peer Median
|
0.00
|
0.00
|
0.00
|
0.00
|
--
|
Revenue Growth
-7.40
Lower than Peers by 16.72
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
-7.40
|
-4.58
|
-55.31
|
15.32
|
60.23
|
|
Peer Median
|
9.33
|
2.48
|
19.31
|
59.50
|
--
|
EBIT Growth
176.70
Higher than Peers by 83.98
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
176.70
|
18.43
|
-130.45
|
8.76
|
104.81
|
|
Peer Median
|
92.72
|
40.29
|
-6.52
|
243.96
|
--
|
Net Profit Growth
-32.44
Lower than Peers by 103.78
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
-32.44
|
139.51
|
-267.45
|
-7.71
|
113.25
|
|
Peer Median
|
71.34
|
17.91
|
172.05
|
273.32
|
--
|
EPS Growth
-32.44
Lower than Peers by 103.78
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
-32.44
|
139.51
|
-267.45
|
-7.71
|
113.24
|
|
Peer Median
|
71.34
|
--
|
283.33
|
258.00
|
--
|
Book Value Growth
4.38
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
4.38
|
6.93
|
-13.99
|
11.26
|
13.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.41
Higher than Peers by 0.27
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
0.41
|
0.37
|
0.72
|
0.50
|
0.43
|
|
Peer Median
|
0.14
|
0.11
|
0.14
|
0.15
|
--
|
Short term debt to equity ratio
0.41
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
0.41
|
0.33
|
0.15
|
0.14
|
0.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.92
Higher than Peers by 0.01
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
1.92
|
1.88
|
2.07
|
2.22
|
2.98
|
|
Peer Median
|
1.91
|
2.45
|
2.04
|
1.32
|
--
|
Quick Ratio
1.69
Higher than Peers by 0.28
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
1.69
|
1.60
|
1.79
|
1.90
|
2.75
|
|
Peer Median
|
1.42
|
1.81
|
1.87
|
0.71
|
--
|
Interest Coverage
5.71
Higher than Peers by 7.09
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
5.71
|
2.61
|
-0.57
|
3.15
|
4.88
|
|
Peer Median
|
-1.38
|
4.03
|
16.53
|
2.55
|
--
|
Operating Efficiency
Debtors to sales
118.07
Higher than Peers by 98.29
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
118.07
|
97.81
|
98.53
|
37.37
|
40.71
|
|
Peer Median
|
19.78
|
16.98
|
21.48
|
13.44
|
--
|
Asset Turnover
0.29
Lower than Peers by 0.82
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
0.29
|
0.29
|
0.28
|
0.68
|
0.72
|
|
Peer Median
|
1.11
|
0.78
|
0.90
|
0.84
|
--
|
Receivable days
408.23
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
408.23
|
366.94
|
332.44
|
132.62
|
136.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
111.84
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
111.84
|
112.22
|
111.46
|
36.13
|
21.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
416.84
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
416.84
|
227.85
|
416.11
|
146.80
|
105.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
103.23
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
103.23
|
251.32
|
27.79
|
21.96
|
52.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
10.61
Lower than Peers by 151.97
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
10.61
|
11.02
|
--
|
15.32
|
5.96
|
|
Peer Median
|
162.58
|
47.34
|
26.10
|
33.46
|
--
|
Price / Book Value
0.45
Lower than Peers by 2.26
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
0.45
|
0.71
|
1.38
|
1.38
|
0.65
|
|
Peer Median
|
2.70
|
1.79
|
3.17
|
3.67
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
5.58
Higher than Peers by 25.54
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
5.58
|
18.37
|
165.56
|
6.44
|
3.19
|
|
Peer Median
|
-19.96
|
20.34
|
9.39
|
27.76
|
--
|
Market Cap
4
Lower than Peers by 50
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
4
|
7
|
12
|
14
|
6
|
|
Peer Median
|
55
|
32
|
45
|
42
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
